HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
HealthEquity, Inc (HQY) PT Raised to $61 at Baird
March 20, 2018 8:20 AM EDTBaird raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $61.00 (from $49.00) while maintaining a Neutral rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $70 at SunTrust Robinson Humphrey
March 20, 2018 5:06 AM EDTSunTrust Robinson Humphrey raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $70.00 (from $60.00) while maintaining a Buy rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $66 at KeyBanc
March 20, 2018 4:21 AM EDTKeyBanc raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $66.00 (from $62.00) while maintaining a Overweight rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $68 at Oppenheimer
March 20, 2018 2:24 AM EDTOppenheimer raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $68.00 (from $58.00) while maintaining a Outperform rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $65 at Cantor Fitzgerald Following 4Q
March 20, 2018 2:20 AM EDTCantor Fitzgerald raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $65.00 (from $60.00) while maintaining a Overweight rating following the company's 4Q earnings report. HQY revenue of $60.4 million, above FactSet consensus and estimates of $58 million. Adjusted EBITDA grew 44.5% as the company continues to scale.... More
